Patents by Inventor John A. Rambosek

John A. Rambosek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6071713
    Abstract: A bioprocess for preparing adipoyl-7-ACA comprising the steps: (a) transforming cells of a strain of Penicillium chrysogenum which produces isopenicillin N with an expression vector containing DNA encoding an enzyme, having expandase activity capable of accepting adipoyl 6-APA as a substrate, an enzyme having hydroxylase activity capable of accepting adipoyl-7-ADCA as a substrate and an enzyme having acetyl transferase activity capable of accepting adipoyl 7-ADAC as a substrate; (b) culturing the transformed cells from step a) in a suitable culture medium containing an adipate feedstock, wherein said cells produce adipoyl 6-APA; and (c) culturing the transformed cells producing adipoyl 6-APA of step b) under conditions suitable for expression of said DNA encoding enzyme, thereby producing the end product adipoyl-7-ACA.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: June 6, 2000
    Assignee: Gist-Brocades B.V.
    Inventors: Michael J. Conder, John A. Rambosek, Phyllis C. McAda, Christopher D. Reeves
  • Patent number: 6017726
    Abstract: A process for making 7-aminodeacetyl-cephalosporanic acid (7-ADAC).
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: January 25, 2000
    Assignee: Gist-Brocades B.V.
    Inventors: Michael J. Conder, John A. Rambosek, Phyllis C. McAda, Christopher D. Reeves
  • Patent number: 5834286
    Abstract: The present invention provides a recombinant combination strain which is capable of over-expressing at least two different genes under two separate promoters in filamentous fungi. The genes encode phytase and pH 2.5 acid phosphatase. Mixtures containing desired ratios of the two enzymes are prepared by recombinant DNA techniques. The enzyme mixtures show a cooperative effect in the degradation of phytic acid and its salts. The preferred ratios of the two enzymes are from about 3:1 to about 16:1.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: November 10, 1998
    Assignee: Rohm Enzyme Finland Oy
    Inventors: Helena K. M. Nevalainen, Marja T. Paloheimo, Richard B. Fagerstrom, Arja S. K. Miettinen-Oinonen, Marja K. Turunen, John A. Rambosek, Christopher S. Piddington, Christine S. Houston, Michael A. Cantrell
  • Patent number: 5830733
    Abstract: The present invention provides a nucleic acid molecule encoding a phytase. The present invention also provides a nucleic acid molecule encoding a pH 2.5 acid phosphatase. Also provided are vectors, host cells, and a method of overexpressing phytate degrading enzymes.
    Type: Grant
    Filed: March 1, 1996
    Date of Patent: November 3, 1998
    Assignee: Rohm Enzyme Finland Oy
    Inventors: Helena K. M. Nevalainen, Marja T. Paloheimo, Arja S. K. Miettinen-Oinonen, Tuula K. Torkkeli, Michael Cantrell, Christopher S. Piddington, John A. Rambosek, Marja K. Turunen, Richard B. Fagerstrom, Christine S. Houston
  • Patent number: 5780292
    Abstract: A highly efficient overexpression system for phytase and pH 2.5 acid phosphatase in Trichoderma is described. This system results in enzyme compositions that are especially useful in the animal feed industry.
    Type: Grant
    Filed: July 31, 1992
    Date of Patent: July 14, 1998
    Assignee: Alko Group Ltd.
    Inventors: Helena K. M. Nevalainen, Marja T. Paloheimo, Aria S. K. Miettinen-Oinonen, Tuula K. Torkkeli, Michael Cantrell, Cristopher S. Piddington, John A. Rambosek, Marja K. Turunen, Richard B. Fagerstrom
  • Patent number: 5629171
    Abstract: Important intermediates for preparing cephalosporin antibiotics, 7-amino-cephalosporanic acid (7-ACA) and 7-aminodeacetylcephalosporanic acid (7-ADAC), are prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); followed by the in situ expression of the following genes with which the P. chrysogenum has been transformed:1) an expandase gene, whose expression product converts the adipoyl-6-APA by ring expansion to adipoyl-7-ADCA;2) an hydroxylase gene whose expression product converts the 3-methyl side chain of adipoyl-7-ADCA to 3-hydroxymethyl, to give the first product, 7-aminodeacetylcephalosporanic acid (7-ADAC); and3) an acetyltransferase gene whose expression product converts the 3-hydroxymethyl side chain to the 3-acetyloxymethyl side chain of 7-ACA. The final product, 7-ACA, is then prepared by cleavage of the adipoyl side chain using an adipoyl acylase.
    Type: Grant
    Filed: May 11, 1995
    Date of Patent: May 13, 1997
    Assignee: Gist-Brocades B.V.
    Inventors: Michael J. Conder, John A. Rambosek, Phyllis C. McAda, Christopher D. Reeves
  • Patent number: 5559005
    Abstract: Important intermediates for preparing cephalosporin antibiotics, 7-amino-cephalosporanic acid (7-ACA) and 7-aminodeacetylcephalosporanic acid (7-ADAC), are prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); followed by the in situ expression of the following genes with which the P. chrysogenum has been transformed:1) an expandase gene, e.g., from Cephalosporium acremonium, whose expression product converts the adipoyl-6-APA by ring expansion to adipoyl-7-ADCA;2) an hydroxylase gene whose expression product converts the 3-methyl side chain of adipoyl-7-ADCA to 3-hydroxymethyl, to give the first product, 7-aminodeacetylcephalosporanic acid (7-ADAC); and3) an acetyltransferase gene whose expression product converts the 3-hydroxymethyl side chain to the 3-acetyloxymethyl side chain of 7-ACA.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: September 24, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Michael J. Conder, Phyllis C. McAda, John A. Rambosek, Christopher D. Reeves
  • Patent number: 5318896
    Abstract: An important intermediate for preparing cephalosporin antibiotics, 7-aminodesacetoxy cephalosporanic acid (7-ADCA), is prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); and the in situ expression of an expandase gene, e.g., from Streptomyces clavuligerus, with which the P. chrysogenum has been transformed, converts the adipoly-6-APA by ring expansion to adipoyl-7-ADCA. The final product, 7-ADCA, is then prepared by cleavage of the adipoyl side chain using an adipoyl acylase. The entire synthesis, accordingly, is carried out using bioprocesses, and is efficient and economical.
    Type: Grant
    Filed: August 28, 1992
    Date of Patent: June 7, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Michael J. Conder, Phyllis C. McAda, John A. Rambosek
  • Patent number: 5229274
    Abstract: A process for the one-step conversion of cephalosporin C and derivatives thereof to the corresponding 7-aminocephalosporanic acid and derivatives comprising treating said cephalosporin C and derivatives with a cephalosporin C amidase enzyme of a recited sequence, the DNA encoding said enzyme, and expression thereof in a suitable host, e.g., Bacillus species under the control of a suitable promoter.
    Type: Grant
    Filed: January 13, 1992
    Date of Patent: July 20, 1993
    Assignee: Merck & Co., Inc.
    Inventors: Mark S. Crawford, David B. Finkelstein, John A. Rambosek
  • Patent number: 5104800
    Abstract: A process for the one-step conversion of cephalosporin C and derivatives thereof to the corresponding 7-aminocephalosporanic acid and derivatives comprising treating said cephalosporin C and derivatives with a cephalosporin C amidase enzyme of a recited sequence, the DNA encoding said enzyme, and expression thereof in a suitable host, e.g., Bacillus species under the control of a suitable promoter.
    Type: Grant
    Filed: June 27, 1989
    Date of Patent: April 14, 1992
    Assignee: Merck & Co., Inc.
    Inventors: Mark S. Crawford, David B. Finkelstein, John A. Rambosek